AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Intro
This chapter explores the investment journey with Tarsus Pharmaceuticals, particularly its lead drug Xdemvi for treating demodex blepharitis. The discussion includes initial skepticism, financial performance, and strategies for navigating risks in biotechnology investments.